David J Adams Selected Research

Mitogen Receptors (Mitogen Receptor)

9/2020	N-acetyl-d-glucosamine-conjugated PAMAM dendrimers as dual receptor-targeting nanocarriers for anticancer drug delivery.
11/2016	Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Adams Research Topics

Disease

65	Neoplasms (Cancer) 01/2022 - 09/2003
29	Melanoma (Melanoma, Malignant) 01/2022 - 10/2011
21	Pain (Aches) 01/2022 - 06/2004
18	Neuralgia (Stump Neuralgia) 01/2022 - 08/2006
12	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2014
11	Chronic Pain 01/2021 - 08/2004
8	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2010
7	Leukemia 08/2012 - 02/2002
6	Lymphoma (Lymphomas) 10/2018 - 07/2002
5	Ganglion Cysts (Ganglion) 01/2021 - 09/2003
5	Breast Neoplasms (Breast Cancer) 04/2016 - 01/2006
4	Inflammation (Inflammations) 01/2022 - 03/2008
4	Adenocarcinoma 12/2021 - 04/2012
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 02/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2010
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2018
3	Adenoma (Adenomas) 12/2021 - 01/2015
3	Osteoporosis 01/2021 - 10/2017
3	Lung Neoplasms (Lung Cancer) 09/2020 - 01/2015
3	Hypersensitivity (Allergy) 01/2019 - 06/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2018 - 08/2013
3	Visceral Pain 01/2018 - 01/2018
3	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 04/2011
3	Hyperplasia 12/2014 - 10/2006
2	Hyperalgesia 01/2021 - 07/2013
2	Osteoarthritis 01/2021 - 08/2006
2	Carcinogenesis 11/2020 - 02/2017
2	Thrombosis (Thrombus) 01/2019 - 12/2018
2	Epilepsy (Aura) 01/2018 - 01/2011
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018 - 01/2018
2	Infections 01/2017 - 12/2009
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2015 - 02/2002
2	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 01/2015
2	Schizophrenia (Dementia Praecox) 03/2015 - 02/2012
2	Alzheimer Disease (Alzheimer's Disease) 03/2015 - 10/2014

Drug/Important Bio-Agent (IBA)

24	Conotoxins (Conotoxin)IBA 01/2022 - 06/2004
20	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2005
16	Peptides (Polypeptides)IBA 01/2022 - 08/2006
16	Pharmaceutical PreparationsIBA 01/2021 - 09/2003
15	Analgesics (Analgesic Drugs)IBA 01/2022 - 03/2008
15	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2010
14	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2022 - 01/2005
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
9	Gemcitabine FDA Link 01/2016 - 02/2002
8	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2006
7	CamptothecinIBA 09/2020 - 09/2003
6	Ion Channels (Ion Channel)IBA 01/2018 - 09/2007
5	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2020 - 09/2003
5	Docetaxel (Taxotere)FDA Link 04/2016 - 01/2014
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
4	VenomsIBA 01/2022 - 10/2008
4	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2006
4	Biological ProductsIBA 01/2021 - 01/2005
4	CarcinogensIBA 11/2020 - 01/2015
4	LigandsIBA 01/2019 - 04/2010
4	Calcium Channels (Calcium Channel)IBA 01/2018 - 07/2013
4	DisulfidesIBA 12/2014 - 08/2006
3	AntigensIBA 01/2022 - 07/2016
3	SodiumIBA 01/2022 - 01/2017
3	Topotecan (Hycamtin)FDA LinkGeneric 01/2019 - 04/2008
3	IntegrinsIBA 01/2019 - 08/2015
3	cyclic (arginyl- glycyl- aspartyl- phenylalanyl- lysyl)IBA 07/2017 - 08/2015
3	AcidsIBA 07/2016 - 01/2006
3	Protein Isoforms (Isoforms)IBA 01/2016 - 10/2006
3	Dasatinib (BMS 354825)FDA Link 02/2014 - 04/2011
3	Sodium Channels (Sodium Channel)IBA 08/2012 - 06/2004
3	Alkylating AgentsIBA 01/2010 - 01/2006
3	Dihydrotachysterol (AT 10)IBA 02/2003 - 02/2002
2	Ethanol (Ethyl Alcohol)IBA 12/2021 - 01/2017
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 01/2021
2	EpitopesIBA 01/2021 - 10/2018
2	Insulin (Novolin)FDA Link 01/2021 - 02/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 01/2020
2	Mitogen Receptors (Mitogen Receptor)IBA 09/2020 - 11/2016
2	Dendrimers (Dendrons)IBA 09/2020 - 04/2016
2	CateninsIBA 12/2019 - 11/2017
2	olaparibIBA 01/2019 - 01/2010
2	CalciumIBA 01/2019 - 07/2013
2	BombesinIBA 01/2019 - 01/2015
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 09/2003
2	Small Interfering RNA (siRNA)IBA 01/2019 - 05/2012
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 01/2010
2	CollagenIBA 01/2019 - 12/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 12/2018
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2016
2	EnzymesIBA 12/2018 - 02/2015
2	ProdrugsIBA 12/2018 - 04/2011
2	AntibodiesIBA 12/2017 - 04/2005
2	Cadherins (E-Cadherin)IBA 08/2017 - 01/2010
2	Glutamic Acid (Glutamate)FDA Link 07/2017 - 09/2007
2	Deubiquitinating EnzymesIBA 01/2017 - 04/2012
2	NucleotidesIBA 12/2016 - 01/2015
2	Opioid Analgesics (Opioids)IBA 01/2016 - 05/2012
2	Competitive Endogenous RNAIBA 04/2015 - 10/2011

Therapy/Procedure

26	Therapeutics 01/2022 - 02/2002
8	Drug Therapy (Chemotherapy) 11/2020 - 01/2005
3	Transplantation 10/2021 - 08/2010
3	Immunotherapy 12/2019 - 01/2017
2	Ligation 12/2018 - 05/2012
2	Analgesia 01/2018 - 03/2008